Anthera Pharmaceuticals, Inc./ US03674U3005 /
2024-08-21 7:47:54 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.0000USD | - | 1,081 Turnover: .0006 |
-Bid Size: - | -Ask Size: - | 0.0000 | 0.0000 |
GlobeNewswire
2021-11-23
Santhera and ReveraGen Announce Positive Topline Results with Vamorolone after Completion of the VIS...
GlobeNewswire
2021-08-02
Oyster Point Pharma Announces New Chairperson Appointment to Board of Directors
GlobeNewswire
2020-07-08
Atossa Therapeutics Advances Product Development Programs with Multiple Key Hires in Clinical, Regul...
GlobeNewswire
2018-08-31
Report: Developing Opportunities within Anthera Pharmaceuticals, NRG Energy, Antares Pharma, El Poll...
GlobeNewswire
2018-08-22
Global Oral Proteins and Peptides Market 2018-2030 - Current Market Landscape of Orally Administrabl...
GlobeNewswire
2018-06-27
Anthera Pharmaceuticals Announces Withdrawal of its Nasdaq Hearing Request and Suspension of Trading...
GlobeNewswire
2018-05-30
AzurRx Announces Appointment of Dr. James Pennington as Chief Medical Officer
GlobeNewswire
2018-05-04
New Research: Key Drivers of Growth for Global Medical REIT, DXP Enterprises, SJW, FTI Consulting, A...
GlobeNewswire
2018-03-19
Research Report Identifies Anthera Pharmaceuticals, Hancock Holding, MKS Instruments, Second Sight M...
GlobeNewswire
2018-03-12
Anthera Pharmaceuticals Reports Top Line Data from the RESULT Phase 3 Clinical Study of Sollpura
GlobeNewswire
2018-03-05
Anthera Pharmaceuticals Provides Business Update and Reports 2017 Fourth Quarter and Fiscal Year Fin...
GlobeNewswire
2018-02-08
Anthera Pharmaceuticals to Participate in the BIO CEO & Investor Conference and SunTrust Robinson Hu...
GlobeNewswire
2018-02-05
Anthera Concludes Last Patient Visit in the Phase 3 RESULT Clinical Study of Sollpura
GlobeNewswire
2018-01-22
Anthera Announces Positive Outcome of Second Interim Futility Analysis in the Phase 3 RESULT Clinica...
GlobeNewswire
2018-01-17
Report: Exploring Fundamental Drivers Behind Anthera Pharmaceuticals, Alarm, Aptevo Therapeutics, Sh...
GlobeNewswire
2018-01-09
Anthera Pharmaceuticals Announces Second Closing of $15 Million Private Placement Offering
GlobeNewswire
2018-01-08
Anthera Pharmaceuticals Announces Results of Special Meeting of Stockholders